CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 40 filers reported holding CTI BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $15,479,869 | -30.1% | 3,685,683 | 0.0% | 1.07% | -14.1% |
| Q4 2022 | $22,150,955 | +3.3% | 3,685,683 | 0.0% | 1.24% | +16.2% |
| Q3 2022 | $21,451,000 | -55.3% | 3,685,683 | -54.2% | 1.07% | -56.6% |
| Q2 2022 | $48,042,000 | -51.9% | 8,047,228 | +12.7% | 2.47% | -14.4% |
| Q1 2022 | $99,804,000 | +463.6% | 7,140,450 | 0.0% | 2.88% | +705.3% |
| Q4 2021 | $17,708,000 | -15.9% | 7,140,450 | 0.0% | 0.36% | +43.2% |
| Q3 2021 | $21,064,000 | +18.0% | 7,140,450 | 0.0% | 0.25% | +7.3% |
| Q2 2021 | $17,851,000 | -14.1% | 7,140,450 | 0.0% | 0.23% | -50.0% |
| Q1 2021 | $20,779,000 | -9.6% | 7,140,450 | 0.0% | 0.47% | -23.2% |
| Q4 2020 | $22,992,000 | +49.8% | 7,140,450 | 0.0% | 0.61% | -6.6% |
| Q3 2020 | $15,352,000 | +85.3% | 7,140,450 | 0.0% | 0.65% | +95.2% |
| Q2 2020 | $8,283,000 | +26.1% | 7,140,450 | 0.0% | 0.33% | -2.9% |
| Q1 2020 | $6,569,000 | +12.8% | 7,140,450 | +90.4% | 0.34% | +24.7% |
| Q4 2019 | $5,825,000 | +85.6% | 3,750,000 | 0.0% | 0.28% | +5.8% |
| Q3 2019 | $3,139,000 | -2.6% | 3,750,000 | 0.0% | 0.26% | +15.0% |
| Q2 2019 | $3,222,000 | -11.4% | 3,750,000 | 0.0% | 0.23% | +19.6% |
| Q1 2019 | $3,638,000 | +32.9% | 3,750,000 | 0.0% | 0.19% | +73.4% |
| Q4 2018 | $2,738,000 | -66.2% | 3,750,000 | 0.0% | 0.11% | -68.9% |
| Q3 2018 | $8,100,000 | -56.6% | 3,750,000 | 0.0% | 0.35% | -60.0% |
| Q2 2018 | $18,675,000 | +27.7% | 3,750,000 | 0.0% | 0.88% | +34.4% |
| Q1 2018 | $14,625,000 | – | 3,750,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|